MedPath

Hyperpolarized 129Xe MRI Lung Health Cohort

Recruiting
Conditions
Healthy
Registration Number
NCT05766384
Lead Sponsor
University of Kansas Medical Center
Brief Summary

A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Is enrolled in the American Lung Association Lung Health Cohort Study.
  • Has completed CT imaging for the LHC study within 2 years of the scheduled Xe-MRI date.
Exclusion Criteria
  • Pacemaker, internal defibrillator or other implanted electronic devices or any standard MRI contraindications (e.g., claustrophobia, > 140 cm shoulder circumference, dependent on weight distribution).
  • Is pregnant or breastfeeding
  • Oxygen saturation (SpO2) <88% on room air or with supplemental oxygen.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Xe-MRI Apparent Diffusion CoefficientAt baseline imaging timepoint

Correlation of Xe-MRI with FEV1/FVC and other measures of lung function

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

University of Illinois-Chicago

🇺🇸

Chicago, Illinois, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

Duke University

🇺🇸

Durham, North Carolina, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath